A brutal sell-off in a few small caps sat alongside takeover bids, fresh capital raisings and strong gains in medtech. The week split the market in two: buyers chased clear funding and approval news, while weaker stories sank fast after reopening.

Big price swings hit the materials board as deal news, capital raisings and resource updates pulled stocks in opposite directions. Gold M&A stayed busy, while critical minerals names kept feeding the market with drilling, testwork and project studies.

Capital raisings drove the week in ASX tech, with investors backing AI and data centre spending but punishing deep discounts. The biggest moves came from small-cap fundraisings, while AI infrastructure names drew the clearest buying support.